ApprovalTrail

Medical device licence · 76368 · Class 2

STELLANT D INJECTOR SYSTEM

Yes: licensed in Canada

Licence status Issued (active); first licensed February 14, 2008. It is in Health Canada’s list of active licences.
Licence number
76368
Licence holder
Bayer Medical Care Inc. Also Doing Business As Medrad, Inc.Indianola, PA, United States
Risk class
Class II (low to moderate risk)
Licence type
System
First licensed
February 14, 2008
Devices covered
10

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • MEDRAD STELLANT MULTI-PATIENT KIT
  • MEDRAD STELLANT SINGLE PATIENT DISPOSABLE
  • STELLANT D INJECTOR SYSTEM - DISPLAY CONTROL CABLE
  • STELLANT D INJECTOR SYSTEM - IMAGING SYSTEM INTERFACE
  • STELLANT D INJECTOR SYSTEM - INJECTOR HEAD EXTENSION CABLES
  • STELLANT D INJECTOR SYSTEM - P3T ABDOMEN SOFTWARE UPGRADE
  • STELLANT D INJECTOR SYSTEM - P3T CARDIACFLOW SOFTWARE UPGRADE
  • STELLANT D INJECTOR SYSTEM - P3T PULMONARY ANGIOGRAPHY SOFTWARE
  • STELLANT D INJECTOR SYSTEM - REMOTE COILED STARTER SWITCH
  • STELLANT D INJECTOR SYSTEM - SYRINGE HEATER

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “stellant”. A notice may cover another product or only some lots: read it to see what it covers.

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.